Effects of octreotide on propylotiouracil-induced goiter in rats: A quantitative evaluation

Histology and Histopathology

Volumn 13, Issue 3, 1998, Pages 679-682

  Pawlikowski, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Morphometry; Octreotide; PTU; Somatostatin analogs; Thyroid gland; Vascularization

Indexed keywords

LONG ACTING DRUG; OCTREOTIDE; PROPYLTHIOURACIL; SODIUM CHLORIDE; SOMATOSTATIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GOITER; MALE; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; QUANTITATIVE ASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THYROID FOLLICLE; THYROID GLAND; THYROID WEIGHT; VASCULARIZATION;

ANIMALS; ANTITHYROID AGENTS; GOITER; HORMONES; MALE; OCTREOTIDE; PROPYLTHIOURACIL; RATS; RATS, WISTAR; THYROID GLAND;

ANIMALIA;

EID: 0031869590     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Ahren B., Ericsson M., Hedner P., Ingemanson S. and Westergren U. (1978). Somatostatin inhibits thyroid hormone secretion induced by exogenous TSH in man. J. Clin. Endocrinol. Metab. 47, 1156-1159.
2. Ain K.B. and Taylor K.D. (1994). Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. J. Clin. Endocrinol. Metab. 78, 1097-1102
3. Barrie R., Woltering E.A., Hajazadeh H., Mueller C., Ure T. and Fletcher W.S. (1993). Inhibition of angiogenesis by somatostatin-like compounds is structurally-dependent. J. Surg. Res. 55, 446-450.
4. 111In-octreotide scintigraphy. Nuklearmedizin 34, 100-103.